Phased Application Awards in Cancer Prognosis and Prediction

The summary for the Phased Application Awards in Cancer Prognosis and Prediction Federal Grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the government agency that is offering this grant.
Federal Grant Title: Phased Application Awards in Cancer Prognosis and Prediction
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-04-102
Type of Funding: Grant
CFDA Numbers: 93.394
CFDA Descriptions: Cancer Detection and Diagnosis Research
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announcement for details.
Posted Date: May 10, 2004
Creation Date: May 26, 2006
Archive Date: Jun 02, 2006
Total Program Funding:
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Grant Description
The Cancer Diagnosis Program of the National Cancer Institute invites applications for research projects to evaluate the utility and pilot the application of new strategies for determining prognosis or predicting response to therapy. This will provide tools to improve clinical decision-making in the care of cancer patients. This PA provides support for a first phase (R21) for technical development and a second phase (R33) for application and evaluation of clinical utility. The first phase should produce data to demonstrate the technical feasibility of the study design proposed for the second phase, including the analytic performance of the assay or test system on samples comparable to those that will be used in the second phase. The second phase should be designed to test whether application of the strategy will provide clinical benefit to a defined set of cancer patients.
Applicants Eligible for this Grant
County governments Independent school districts State governments Special district governments Public housing authorities/Indian housing authorities City or township governments Private institutions of higher education Small businesses Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-04-102.html http://grants.nih.gov/grants/guide/pa-files/PA-04-102.html
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
Similar Government Grants
Limited Competition: Biospecimen Banks to Support NCI-Clinical Trials Network (NCTN) (U24)
Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01)
Quantitative Imaging for Evaluation of Response to Cancer Therapies (U01)
Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21)
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging...
Image-Guided Cancer Interventions (STTR [R41/R42])
An SBIR Initiative for Image-Guided Cancer Interventions (R43/R44)
In Vivo Cancer Imaging Exploratory/Developmental Grants
More Grants from the National Institutes of Health
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development f...
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development f...
Interventions for Youth who Misuse/Abuse Prescription Stimulant Medications in High School...
Advanced Clinical Trials to test Artificial Pancreas Device Systems in Type 1 Diabetes (UC...
Mucosal Environment and HIV Prevention (MEHP II) (R01)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2014 FederalGrants.com